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caesarean section (CS) makes it the preferred anaesthetic technique. Intraoperative nausea and
vomiting in parturients subjected to CS under spinal anaesthesia is a major drawback of the tech-
nique. Post-spinal hypotension, the sympathetic blockade and associated relative vagal hyperactiv-
ity in addition to intraoperative visceral pain are the most important underlying factors behind the
high rate of IONV during spinal anaesthesia. Ketamine has a unique sympathomimetic and vago-
lytic criteria that may help in reducing the incidence of IONV secondary to spinal-induced hypoten-
sion. This study was an attempt to evaluate the effect of ketamine on the IONV in parturients
subjected to elective CS under spinal anaesthesia.
Patients and methods: Two hundred twenty-nine patients were randomly allocated into two equal
groups: the ketamine group; in which 0.5 mg/kg was infused intravenously in 20 min and the pla-
cebo group; in which normal saline was infused. The two groups were given subarachnoid block
with local anaesthetic hyperbaric 0.5% bupivacaine and intrathecal fentanyl.5268464.
o.com (E.S. Nasr).
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170 A.M. Shabana et al.Results: IV infusion of ketamine was associated with signiﬁcant reduction in the incidence of intra-
operative nausea and hypotensive episodes.
Conclusion: This study demonstrated a beneﬁcial effect of IV infusion of ketamine on IONV in
parturients subjected to elective CS under spinal anaesthesia.
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Intraoperative nausea and vomiting (IONV) during caesarean
section (CS) under spinal anaesthesia is a common complica-
tion with an incidence ranging from 40% to 60% [1–4]. Many
factors may contribute to this high rate of IONV during CS;
sympathetic block and the resultant hypotension secondary
to spinal anaesthesia, visceral pain and vagal stimulation dur-
ing CS are probably the most important factors [5]. Ketamine
has unique central sympatho-mimetic, vagolytic and analgesic
properties [6]. These properties of ketamine are assumed to re-
duce the incidence of spinal induced hypotension. In this study,
we hypothesized that an IV infusion of ketamine would lower
the incidence of intraoperative nausea and vomiting secondary
to spinal-induced hypotension. This placebo-controlled pro-
spective randomized double-blinded study was designed to
evaluate the impact of ketamine on prevention of intra-opera-
tive nausea and vomiting as a primary outcome in parturients
subjected to elective CS under spinal anaesthesia. Maternal
and fetal side effects were considered as a secondary outcome.
2. Patients and methods
After approval by an ethical committee at Mansoura Univer-
sity Hospitals and obtaining a written informed consent from
eligible parturients scheduled for elective caesarean section un-
der spinal anaesthesia, ASA1 and 2 parturients having single-
ton pregnancy were included. Exclusion criteria included
history of motion sickness, post-operative nausea and vomit-
ing, gastrointestinal disease, allergy to (bupivacaine, fentanyl
or metoclopropamide), pregnancy induced hypertension, his-
tory of non-gestational diabetes and history of smoking. Obese
patients (body weight >90 kg), epileptic patients, patients gi-
ven antiemetics or corticosteroids within 24 h before CS, pa-
tients who was heavy sedated (with Ramsy sedation score
more than 3), and patients having any absolute contraindica-
tions to spinal anaesthesia were excluded. Included patients
were randomly (using computer generated randomization ta-
ble) allocated into two equal groups: the ketamine group
(n= 110) and the control group (n= 110).
In the ketamine group, ketamine was diluted to a total vol-
ume of 20 ml via normal saline. Using an infusion pump (Gra-
seby 3100-waltford, Herts-UK), ketamine was given at a dose
of 0.5 mg kg1 over 20 min started while patient back was
being cleaned and scrubbed for spinal anaesthesia before intra-
thecal injection. In the control group, a similar volume of nor-
mal saline was given using the same technique used in the
ketamine group. In order to achieve blindness of the study,
one researcher was involved only in drug preparation accord-
ing to patient’s randomization and group assignment. The
other researcher (anaesthesia provider) gave spinal block,
managed the patient according to the study protocol and re-
corded the intraoperative data.Patients started NPO midnight of the surgery, Ringer lac-
tate infusion in a rate of 1.5 ml/kg1 h1 commenced at 6 am
on the day of surgery through an 18-G peripheral IV cannula,
a 20 ml of 0.3 M sodium citrate given orally 15 min before
shifting the patient to the main operating theatre.
In the waiting area of the operating room, patients were
monitored with ECG, automated noninvasive arterial blood
pressure and pulse oximetry. An average of two readings of
the mean arterial blood pressure (MABP) and heart rate
(HR) were taken 5 min apart and considered the basal read-
ings. Preloading with 10 ml Kg1 of hydoxyethyl starch solu-
tion (6% HES 200/0.5 Braun Melsungen AG-Germany) was
completed within 15–20 min, after which patient was shifted
to the operating room (OR) where the standard monitoring
of ECG, HR, BP and SpO2 was extended.
In the OR, we performed spinal anaesthesia in the sitting
position under complete aseptic technique and skin inﬁltration
with 0.5 ml of 1% lidocaine at site (L3-4 or L4-5) of spinal nee-
dle insertion. We used a spinal needle 25-G pencil point type,
once free ﬂow of clear CSF was obtained a 15 lg fentanyl
loaded in 2 ml syringe was injected intrathecally followed by
a hyperbaric bupivacaine 0.5%. The dose of bupivacaine was
adjusted according to parturients height, 2 ml (10 mg) was gi-
ven to those having a height <155 cm and 2.2 ml (12 mg) was
given if the height was P155 cm. After intrathecal injection,
patients were immediately returned supine with left uterine dis-
placement and supplemented with oxygen 4 L min1 via clear
facemask. Dermatomal level of sensory block was assessed
by pinprick method; T5 was the minimum acceptable level be-
fore surgical incision. Both groups were given the same anaes-
thetic management by well-trained anaesthetists having an
experience more than 10 years in the anaesthesia practice.
Mean arterial blood pressure (MABP) was measured every
1 min for the ﬁrst 10 min then every 2 min until the end of ket-
amine or placebo infusion. Intraoperative hypotension-deﬁned
by MABP less than 20% of the basal reading-was managed by
increasing the infusion rate of Ringer lactate solution concom-
itant with administration increments of 3 mg ephedrine hydro-
chloride. Arterial blood pressure was measured 1 min after
ephedrine injection and if hypotension persists another ephed-
rine bolus was given, atropine sulphate (0.5 mg) was given
when hypotension was associated with bradycardia (HR
<50 beats min1). At the end of CS the incidence of hypoten-
sion (percentage per each group), hypotensive episodes (num-
ber of hypotensive episodes per each group) and increments of
ephedrine hydrochloride in mg. were recorded.
Ramsay Sedation Scale (RSS; 1 = anxious and agitated,
2 = co-operative and tranquil, 3 = drowsy but responsive to
command, 4 = asleep but responsive to glabellar tap,
5 = asleep with a sluggish response to tactile stimulation,
6 = asleep and no response). It was used to measure sedation
level at 5, 10, 15, 20, 25, and 30 min after surgical incision, pa-
tients having RSS 4 or more were rejected.
Table 1 Demographic and haemodynamic data in the keta-
mine and control groups.
Data Ketamine group Control group P value
Age (yr) 29.1 ± 5.6 29.6 ± 6.2 0.569
Weight (Kg) 79.8 ± 8 77.8 ± 8.4 0.077
Height (cm) 161 ± 5.1 160.1 ± 5.9 0.549
Basal MABP mmHg 86.1 ± 8.2 86.3 ± 7.4 0.809
Basal HR; bpm 74.2 ± 9.4 75.7 ± 11.8 0.330
Data are expressed by mean ± SD or absolute number (%),
MABP=mean arterial blood pressure, HR= heart rate,
bpm= beats per min. P value <0.050 is considered signiﬁcant.
Effect of ketamine on intraoperative nausea 171Oxytocin was given immediately after baby delivery and
clamping of the umbilical cord. Using a 10 ml syringe, a 10
units of oxytocin diluted into 10 ml of normal saline was given
incrementally starting by an IV bolus dose of 2 ml (2 units) fol-
lowed by increments of 2 units according to uterine contractil-
ity as per the obstetrician opinion. At the end of surgery; the
total amount of oxytocin units administered, the technique
of uterine repair (Either exteriorized or insitu) and duration
was recorded. Patients given uterotonics other than oxytocin
were rejected from the study. We replaced rejected patients
from the study according to group assignment.
During surgery; intraoperative pain was managed by
administration of 20 lg fentanyl given as IV bolus. At time
of consent and again before the administration of spinal anaes-
thesia, patients were reminded to report any side effect or dis-
comfort including nausea. Leading questions about nausea
were avoided. Intraoperative nausea was recorded as follow
(no nausea = 0, nausea only = 1, nausea and retching = 2),
also the timing of IONV (during infusion or after) was re-
corded. Nausea with retching or vomiting were managed by
a rescue dose of 10 mg metoclopramide diluted in a 10 ml of
normal saline and given IV slowly, while nausea only was man-
aged by assurance. Maternal side effects (such as desaturation,
hallucinations) as well as fetal well-being (assessed with the
Apgar scoring) were recorded.
Upon completion of the CS, parturients were transported
to the post-anaesthesia care unit (PACU) where routine mon-
itoring of BP, ECG, and SpO2 in addition to oxygen supple-
mentation were applied to all patients under the care of
PACU nurses then all patients were discharged and shifted
uneventfully to the ward.3. Statistical analysis
Statistical analysis was performed using the Statistical Package
for the Social Sciences (SPSS for Windows, version 17). Based
on previous investigations [1–4] which reported an incidence
between 40% and 60% of intraoperative nausea of parturients
operated for CS under neuraxial anaesthesia, assuming 30% is
the predicted incidence in the control group, to achieve 50%
reduction in the incidence of intraoperative nausea (the pri-
mary outcome) at two-sided signiﬁcance level 0.050% and
80% power, it was calculated that a minimum of 110 patients
were required in each group. Normally distributed numerical
data were presented by its mean and standard deviation
(SD), while in-between group differences were compared
parametrically using the independent-samples Student t test.
Non-normally distributed numerical data were presented as
absolute number (percent or range), while inter-group
differences were compared non-parametrically using the
Mann–Whitney U test. Signiﬁcance level was set at P< 0.050.4. Results
A total number of 229 patients were enroled in this study, 9 pa-
tients were rejected, 2 patients required general anaesthesia one
because of failed block and the second because of inadequate
block, 5 patients given methyl-ergometrine according to the
obstetrician opinion, 1 patient had RSS = 4, and 1 patient
was given midazoalm immediately after delivery as she was
very anxious.There was neither maternal, fetal mortality, nor serious re-
gional complications in the form of total spinal, paraplegia,
epidural abscess, haematoma. All patients maintained a Spo2
level above 94%.
There was no signiﬁcant difference in patient’s data includ-
ing age, weight, height, basal MABP and basal heart rate with
P values 0.569, 0.077, 0.549, 0.809, and 0.330 respectively,
(Table 1). Obstetric data including sensory block, bupivacaine
dose, uterine exteriorization, number of parturients underwent
bilateral tubal ligation (BTL), duration from skin incision to
uterine repair, operative time, oxytocin requirements showed
no signiﬁcant statistical difference between the two groups: P
values 0.531, 0.199, 0.440, 0.801, 0.531, 0.585, and 0.277
respectively, (Table 2). Apgar scores at 1 and 5 min did not
show signiﬁcant changes with P values 0.196 and 0.229 respec-
tively (Table 2).
The lower incidence of intraoperative hypotension (35.5%
vs 45.5%) was not signiﬁcant (P value 0.214), however the
number of hypotensive episodes and ephedrine requirements
increased signiﬁcantly in the placebo group compared with
ketamine group P values 0.018 and 0.016 respectively. Five
patients (4 in the placebo group and 1 in the ketamine group)
recorded concomitant hypotension and bradycardia and were
given IV bolus 0.5 mg atropine sulphate.
The incidence of intraoperative nausea was 20.9% in the
ketamine group compared with 40.9% in the placebo group,
which was statistically signiﬁcant (P value 0.004). Both vomit-
ing episodes and number of patients who required rescue anti-
emetics in the ketamine group compared with placebo one
(2.3% vs 4.6% and 6 vs 11 respectively) were not statistically
signiﬁcant P values 0.702 and 0.423 Table 3. The majority of
hypotensive episodes occurred during ﬁrst 20 min of operation
(infusion period) in both ketamine and placebo groups (85.7%
and 84.3% respectively), similarly incidence of nausea during
infusion period in both ketamine and placebo groups was
73.9% and 75.6% respectively.
There was no signiﬁcant reduction in the incidence of pain,
RSS, hallucinations between the two groups (Tables 3 and 4).
5. Discussion
The use of ketamine in the current study was associated with
signiﬁcant reduction in the incidence of intra-operative nausea
and hypotensive episodes in parturients subjected to elective
CS under spinal anaesthesia; however, the reduction in the
incidence of intraoperative vomiting and rescue antiemetic
requirements was not statistically signiﬁcant.
Table 2 Anaesthetic and obstetric data in the ketamine and control groups.
Data Ketamine group Control group P value
Sensory block T4(T2–T6) T4(T2–T5) 0.531
Bupivacaine dose 11.8 ± 0.7 11.6 ± 0.8 0.199
Exteriorization of uterus; n 39 (45.9) 42 (40) 0.440
BTL; n 8(7.1) 7(5.9) 0.801
Time from skin incision to closure of uterine incision time 17.7 ± 4.7 17.3 ± 4.8 0.533
Operative time; min 52.6 ± 7.7 52 ± 8.1 0.585
Oxytocin dose; U 12.6 ± 3.4 13.1 ± 3.6 0.277
Apgar score 1st min 7.9 ± 0.9 7.8 ± 0.9 0.196
Apgar score 5th min 8.5 ± 0.7 8.7 ± 0.7 0.229
Data are expressed by mean ± SD or absolute number (%) BTL = bilateral tubal ligation, P value <0.050 is considered signiﬁcant.
Table 3 Intraoperative hypotension and ephedrine requirements, pain and rescue fentanyl increments, episodes of intraoperative
nausea and vomiting, and rescue antiemetic requirements and incidence of hallucinations and nystagmus in the two groups.
Data Ketamine group (n= 110) Control group (n= 110) P value
Intraoperative hypotension 39 (35.5) 50 (45.5) 0.214
hypotensive episodes Total no 77 133 0.018
during 1st 20 min 64 118 –
After 1st 20 min 13 15 –
Ephedrine dose in mg 2.1 (0–9) 4.03 (0–15) 0.016
Intraoperative nausea Total no 23 (20.9) 45 (40.9) 0.004
during 1st 20 min 17 34 –
After the 1st 20 min 6 11 –
Intraoperative vomiting 3 (2.7) 5 (4.5) 0.702
Rescue antiemetics 6 (5.5) 9 (8.2) 0.423
pain 3 (2.7) 4 (3.6) 1.000
Hallucinations 1 (0.9) 0 (0) 0.317
Data are expressed by mean ± SD, median (range) or absolute number (%), No = number of patients, min = minutes, value <0.050 is
considered signiﬁcant.
Table 4 Ramsey sedation score (RSS) in both ketamine and control groups.
Ketamine group (n= 85) Control group (n= 85) P value
1 2 3 4 5 6 1 2 3 4 5 6
5 min 0 82 3 0 0 0 0 85 0 0 0 0 0.081
10 min 0 83 2 0 0 0 0 85 0 0 0 0 0.156
15 min 0 82 3 0 0 0 0 85 0 0 0 0 0.081
20 min 0 82 3 0 0 0 0 85 0 0 0 0 0.081
25 min 0 83 2 0 0 0 0 85 0 0 0 0 0.156
30 min 0 84 1 0 0 0 0 85 0 0 0 0 0.371
Data are expressed by absolute number of patients under each RSS, P value <0.050 is considered signiﬁcant.
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anaesthesia compared to general anaesthesia encouraged
anaesthetists to use it as the gold standard for the anaesthetic
management of parturient subjected to CS. Unfortunately
intraoperative hypotension, and IONV are signiﬁcant and irri-
tating drawback of spinal anaesthesia [1–4].
IONV is an uncomfortable feeling for patients, upsets
obstetricians, distresses anaesthetists, and may increases the
risk of visceral injury during surgery because of the involun-
tary uncontrolled abdominal movements.
Spinal hypotension and gastrointestinal hyperactivity re-
sulted from relative vagal hyperactivity secondary to spinal
anaesthesia plays a signiﬁcant role [5,7], Datta et al. foundavoidance of spinal hypotension during CS reduced emetic epi-
sodes by 6–7 folds [7].
Several investigators studied different medications to re-
duce IONV in parturients undergoing CS under spinal anaes-
thesia; Santos and Datta [1], and Mandell et al. [2] used
droperidol in an IV dose of 2.5 mg and 0.5 mg – respec-
tively-vs placebo and they found droperidol caused a signiﬁ-
cant reduction in the incidence of nausea compared to the
placebo groups (P value 0.024 and 0.001). Fuji and his col-
leagues [3] investigated the preventive effect of IV granisteron
3 mg, metoclopropamide 10 mg, droperidol 1.25 mg against
placebo; they found that the three drugs were similarly effec-
tive in reduction of intraoperative nausea compared to placebo
Effect of ketamine on intraoperative nausea 173effect (P value 0.001). In contrast to Fujii et al. [3] result, Balki
and his colleagues [4] found grnisteron ineffective in preven-
tion of intraoperative nausea in parturients given spinal anaes-
thesia for CS and they postulated this difference to the use of
more strict control of the causative factors of IONV specially
hypotension. Glycopyrrolate was studied in prevention of
intraoperative nausea during CS because of its vagolytic
effect and it reduced the incidence of IONV from 68% in
the placebo group to 42% in the study group [8]. Fujii and
Numazaki [9] used the IV anaesthetic agent propofol in differ-
ent sub-hypnotic doses; they reported that a dose of 1 and
2 mg kg1 h1 reduced intraoperative nausea signiﬁcantly
compared to placebo, whereas a dose of 0.5 mg kg1 h1 was
not effective compared with placebo.
Despite ketamine is a very known, old and established
drug, we are not aware of any study that has speciﬁcally
looked at the effect of a ketamine infusion on the incidence
of nausea and vomiting secondary to spinal anaesthesia in-
duced IONV secondary to spinal-induced hypotension in elec-
tive caesarean section. Ketamine is an intravenous dissociative
anaesthetic agent related to phencyclidine group which works
by antagonizing N-methyle D-aspartate (NMDA) receptors
[6]. Because of its unique analgesic and dissociative criteria
in addition to the distinct symatho-mimetic, vagolytic pharma-
cological properties, ketamine is used frequently in anaesthesia
practice for purposes of analgesia, sedation and induction of
anaesthesia many years ago (9). These criteria especially sym-
patho-mimetic and vagolytic properties encouraged us to con-
duct this study.
In our study the incidence of hypotension in the control
group was less compared to previous reports [10,11]. This
can be explained by the use of prehydration with colloid ﬂuid
that was reported by Ngan Kee et al.; found that colloid in the
form of gelfusine or heastril preloading was associated with
less incidence and severity of hypotension during CS under re-
gional anaesthesia [12,13]. Titrating bupivacaine dose accord-
ing to the patient height and maintaining left uterine
displacement are other factors.
The use of ketamine as IV induction agent in haemodynam-
ically-compromised patients subjected to emergent surgical
interventions was shown to increase mean arterial blood pres-
sure by a mean of 10% when compared to basal readings as
reported by White PF [14].
In our study, the frequency of hypotensive episodes during
infusion period was nearly twice in the placebo group com-
pared with ketamine group (118 vs 64) with signiﬁcant statisti-
cal difference in the total hyptensive episodes between the two
groups; this could be explained by the sympatho-mimetic effect
as well as vagolytic effect of ketamine.
Compared to other studies [1–4], the incidence of intraoper-
ative nausea was less and this can be explained by the less inci-
dence of hypotension. The use of intrathecal fentanyl and its
related analgesia as reported by Manullang et al. [15], and
the use of ketamine in the current study had an additional ef-
fect in reducing intraoperative nausea signiﬁcantly compared
with placebo group. The marked reduction in the incidence
of hypotensive episodes during infusion-nearly to half-in keta-
mine group compared to placebo group could explain a strong
relation to the signiﬁcant reduction in the incidence of intraop-
erative nausea during spinal anaesthesia for CS. This effect
was conﬁrmed by other studies that have shown that if intra-
operative hypotension is eliminated, the incidence of nauseaand vomiting can be reduced to less than 5% [16]. Low dose
of IV ketamine was shown to reduce the incidence of postop-
erative nausea/vomiting score in another types of surgeries as
reported by Yamauchi et al. [17]. They found that administra-
tion of a low-dose ketamine infusion at skin incision and con-
tinues post-operatively not only improved the analgesic effects,
but also it reduced postoperative nausea and vomiting. This
ﬁnding is agree with the result of our study despite different
explanation.
Both maternal and fetal safety of ketamine in CS is docu-
mented; Ngan Kee et al. [18] compared the effect of ketamine
induction vs thiopental induction on postoperative analgesia in
elective CS, they found that patients in the ketamine group re-
quired less analgesic drugs in the ﬁrst 24 h compared with thio-
pental group and the neonatal apgar score was comparable
without inter-group signiﬁcant changes In another study Niel-
sen and Holasek [19] studied ketamine as an induction agent in
CS and found an excellent Apgar scores (mean 9.1 at 1 min
and 9.9 at 5 min) associated with ketamine induction. These
studies agree with our results that did not detect any signiﬁcant
changes in the apgar scores between the two groups at both 1
and 5 min Apgar scores (P values 0.195, and 0.229).
The non-signiﬁcant difference in the sedation level mea-
sured by RSS between the two groups (Table 4) disagrees with
the result of Saricalouge et al. study [20] which investigated the
impact of intravenous ketamine on ischaemia-reperfusion in-
jury in patients subjected to knee arthroscopy under spinal
anaesthesia and found signiﬁcantly higher RSS in the ketamine
group. This difference could be explained by the higher keta-
mine dose and the use of midazoalm in their study [20],
although a higher sedation score was reported in their study
[20], it was not associated with increased incidence of either
respiratory depression or hallucinations in the ketamine group
which agrees with the result of the our study.
We speculate that; despite the reduction in the incidence of
hypotension was insigniﬁcant however the frequency of hypo-
tensive episodes was signiﬁcantly less in the ketamine group,
hence the ephedrine requirements, compared with placebo
group could explain the statistically signiﬁcant reduction in
the incidence of intraoperative nausea in ketamine group com-
pared to the placebo one.
In this study, we used a single dose of ketamine which could
be considered one of the limitations of the study, further study
may be required to study the effect of different ketamine doses.
We excluded psychologically disturbed patients without for-
mal assessment by a more psychiatrist, which is considered an-
other limitation?
In conclusion, the current study demonstrated that IV keta-
mine infusion in parturients subjected to elective CS under
spinal anaesthesia effectively reduced intraoperative nausea
which was associated with the marked reduction in the inci-
dence of hypotensive episodes compared to placebo group.References
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